2-(2-phenethyl) chromone and lignan hybrid and application thereof

By isolating the hybrid thick-leaf agarwood formed by 2-(2-phenethyl)chromone and lignan from thick-leaf agarwood trees, the problem of insufficient research on new compounds in agarwood was solved and the confrontation was achieved The verification of inflammation activity demonstrated significant anti-inflammatory effects.

CN118994185AActive Publication Date: 2024-11-22INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI

Patent Information

Application Number
CN202410992597.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-22
Estimated Expiration
2044-07-23

AI Technical Summary

Technical Problem

There is a lack of in-depth research on dimer or trimer hybrids in existing agarwood studies, and the discovery of new compounds is relatively rare, which affects the discovery of structurally novel compounds in agarwood.

Method used

The hybrid formed by 2-(2-phenethyl)chromanone and lignan was isolated from the thick-leaf agarwood tree, and the new compound agarwood (aquicrassnol) was identified by multi-step chromatography and spectroscopy. and verify its anti-inflammatory activity.

Benefits of technology

Thick-leaf agarwood alcohol has an inhibitory effect on the production of nitric oxide in lipopolysaccharide-induced mouse mononuclear macrophages. The half-inhibitory concentration value was 47.53±2.14μmol/L, showing a significant anti-inflammatory effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994185A_ABST
    Figure CN118994185A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of agilawood, and particularly relates to a 2-(2-phenethyl) chromone and lignan hybrid and application thereof. The method comprises the following steps: by taking agilawood produced by agilawood trees as a raw material, carrying out reflux extraction, separating and purifying by sequentially adopting various chromatographic technologies such as silica gel, Sephadex LH-20 gel and high performance liquid chromatography to obtain a monomeric compound, identifying the structure of the monomeric compound by virtue of spectrum methods such as mass spectrum and nuclear magnetic resonance in combination with physicochemical properties, and carrying out SciFinder retrieval to obtain a new compound named as agilawood. The 2-(2-phenethyl) chromone and lignan compound is a heterocomplex formed by 2-(2-phenethyl) chromone and lignan and is found in agilawood for the first time. Experiments prove that the compound has an inhibition effect on generation of nitric oxide by lipopolysaccharide-induced mouse mononuclear macrophage RAW264.7, the half inhibition concentration value of the compound is 47.53 + / -2.14 mu mol / L, and the compound has anti-inflammatory activity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of agarwood, and specifically relates to a 2-(2-phenylethyl) chromone and lignan hybrid and application thereof. Background Art

[0002] Agarwood is the resinous wood of Aquilaria Lam. or Gyrinops Gaertn. of the Thymelaeaceae family. It is a natural fragrance and a precious traditional medicinal material. At present, the main plant sources of agarwood traded on the international market are A. sinensis (Lour.) Spreng., A. malaccensis Lam., A. filaria (Oken) Merr. and A. crassna Pierre ex Lecomte. In the past, a large number of studies on agarwood from the above four plant sources, as well as agarwood produced by A. walla Gaertn and G. salicifolia Ridl, it was found that 2-(2-phenylethyl) chromone and sesquiterpenes are the two main characteristic components of agarwood. Most of the 2-(2-phenylethyl) chromone isolated from agarwood in the early stage exist in the form of monomers, and only a few are dimers or trimers. These uncommon compounds are a relatively special class of chemical components in agarwood. Therefore, the study of dimer or trimer hybrids in agarwood provides important clues for discovering more novel compounds in agarwood. Summary of the invention

[0003] The present invention provides a 2-(2-phenylethyl) chromone and lignan hybrid and application thereof. The compound is separated from agarwood produced by Aquilaria crassifolia and is the first heteropolymer formed by 2-(2-phenylethyl) chromone and lignan found in agarwood. It is a new compound retrieved by SciFinder and named aquicrassnol, and exhibits anti-inflammatory activity.

[0004] The technical solution of the present invention is achieved in this way:

[0005] A 2-(2-phenylethyl) chromone and lignan hybrid, named as linalool, has a structure as shown in Formula I:

[0006]

[0007] The preparation method of the above-mentioned 2-(2-phenylethyl) chromone and lignan hybrid comprises the following steps:

[0008] (1) extracting the dried and crushed agarwood wood by heating and refluxing with ethanol water with a volume concentration of 95%, recovering the ethanol under reduced pressure until there is no alcohol smell, obtaining an ethanol extract, dispersing the ethanol extract with water into a suspension, extracting with acetic acid, and concentrating to obtain an acetic acid extract;

[0009] (2) subjecting the acetic acid ester extract to vacuum column chromatography and eluting with chloroform-methanol to obtain 11 fractions Fr.1-11;

[0010] (3) The eighth fraction Fr.8 was subjected to MCI column chromatography and gradient eluted with methanol / water to obtain nine fractions Fr.8-1 to 8-9; the eighth fraction Fr.8-8 was subjected to reverse phase silica gel column chromatography and gradient eluted with methanol-water to obtain five fractions Fr.8-8-1 to 8-8-5;

[0011] (4) The second fraction Fr.8-8-2 was separated by gel column chromatography and eluted with chloroform-methanol to obtain three fractions Fr.8-8-2-1 to 8-8-2-3. The first fraction Fr.8-8-2-1 was purified and separated by semi-preparative high performance liquid chromatography (HPLC) to obtain a compound whose structure is shown in the above formula I.

[0012] Furthermore, in the step (1), the agarwood is agarwood produced by the Aquilaria australis plant.

[0013] Furthermore, in the step (1), reflux extraction is performed 3 times and extraction is performed 3 times.

[0014] Furthermore, in the step (2), the volume ratio of chloroform to methanol is 1:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, and 0:1, respectively; in the step (3), the volume ratio of methanol / water used for eluting the fraction Fr.8 is 1:1, 3:2, 7:3, 4:1, 9:1, and 1:0, respectively; the volume ratio of methanol to water used for eluting the fraction Fr.8-8 is 3:7, 2:3, 1:1, 3:2, 7:3, 4:1, 9:1, and 1:0, respectively.

[0015] Furthermore, in the step (4), the fraction Fr.8-8-2 is separated by Sephadex LH-20 gel column chromatography, and the volume ratio of chloroform to methanol used for elution is 1:1.

[0016] Further, in step (4), the HPLC purification conditions are: C 18 The column was used, the mobile phase was acetonitrile-water in a volume ratio of 2:3, and the flow rate was 4 mL / min; the retention time of the compound represented by formula I was 15.12 min.

[0017] The application of the 2-(2-phenylethyl) chromone and lignan hybrid in the preparation of anti-inflammatory preparations.

[0018] Furthermore, the 2-(2-phenylethyl) chromone and lignan hybrid can inhibit the production of nitric oxide in mouse mononuclear macrophage RAW264.7 cells induced by lipopolysaccharide.

[0019] An anti-inflammatory preparation contains the above-mentioned 2-(2-phenylethyl) chromone and lignan hybrid.

[0020] Beneficial effects of the present invention:

[0021] The present invention uses agarwood from the original plant Aquilaria australis as raw material, undergoes reflux extraction, and then sequentially uses silica gel, Sephadex LH-20 gel, high performance liquid chromatography and other chromatographic techniques for separation and purification to obtain a monomer compound, identifies its structure through mass spectrometry, nuclear magnetic resonance and other spectral methods combined with physical and chemical properties, retrieves it as a new compound through SciFinder, and names it aquicrassnol. The compound is the first heterocomplex formed by 2-(2-phenylethyl) chromone and lignans discovered in agarwood. It has been verified by experiments that the compound has an inhibitory effect on the production of nitric oxide by mouse mononuclear macrophages RAW264.7 induced by lipopolysaccharide, and its half-maximal inhibitory concentration value is 47.53±2.14μmol / L, which has an anti-inflammatory effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0023] Figure 1 For compound 1 1 H NMR spectrum (500 MHz, CDCl3).

[0024] Figure 2 Compound 1 13 C NMR spectrum (125 MHz, CDCl3).

[0025] Figure 3 Compound 1 1 H- 1 H COSY diagram.

[0026] Figure 4 HSQC pattern of compound 1.

[0027] Figure 5HMBC pattern of compound 1.

[0028] Figure 6 ROESY pattern of compound 1.

[0029] Figure 7 are the key 2D NMR related signals of compound 1.

[0030] Figure 8 The CD spectrum and chromophore exciton chirality of compound 1.

[0031] Fig. 9 is the chemical structure of compound 1. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] Example 1 Isolation and identification of compounds

[0034] 1 Materials

[0035] The agarwood samples were collected in Vientiane, Laos. The original plant was identified by Associate Researcher Huang Shengzhuo from the Institute of Tropical Biotechnology, Chinese Academy of Tropical Agricultural Sciences as Aquilaria crassna of the genus Aquilaria in the family Thymelaeaceae. The voucher specimen (No. 20140909) is preserved in the Institute of Tropical Biotechnology, Chinese Academy of Tropical Agricultural Sciences.

[0036] 2 Extraction and separation

[0037] The dried and crushed agarwood (2.2 kg) was heated and refluxed with 95% ethanol water (volume concentration) for extraction 3 times, 10 L of ethanol was added each time, and the ethanol was recovered under reduced pressure until there was no alcohol taste, to obtain an ethanol extract (296.0 g), the ethanol extract was dispersed into a suspension with water, and extracted with acetic acid ester and n-butanol esters for 3 times respectively, and concentrated to obtain acetic acid ester extract and n-butanol extract respectively. The acetic acid ester extract (191.6 g) was subjected to vacuum column chromatography, eluted with chloroform-methanol (volume ratios of 1:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, 0:1), and the same components were combined by thin layer chromatography (the same below) to obtain 11 fractions Fr.1-11. The 8th fraction Fr.8 was subjected to MCI column chromatography and eluted with methanol / water (volume ratios of 1:1, 3:2, 7:3, 4:1, 9:1, 1:0, 2.5 L for each gradient) to obtain 9 fractions Fr.8-1 to 8-9.

[0038] The 8th fraction Fr.8-8 (13.5 g) was taken and subjected to reverse phase silica gel column chromatography, eluted with methanol-water (volume ratios of 3:7, 2:3, 1:1, 3:2, 7:3, 4:1, 9:1, 1:0, 2.5 L for each gradient) to obtain 5 fractions Fr.8-8-1 to 8-8-5.

[0039] The second fraction Fr.8-8-2 (1.2 g) was purified by Sephadex LH-20 gel column chromatography and eluted with chloroform-methanol (volume ratio of 1:1) to obtain three fractions Fr.8-8-2-1 to 8-8-2-3. Fr.8-8-2-1 was purified by semi-preparative HPLC (C 18 Column, acetonitrile-water (volume ratio 2:3, flow rate 4 mL / min) to separate and purify compound 1 (3.1 mg, t R =15.12min).

[0040] 3 Structure identification

[0041] Compound 1 is a pale yellow amorphous solid. (c 0.15, MeOH); 212(4.83),260(4.27),283(3.65); 3414,2928,1657,1599,1508,1453,1239,1121,1029,476; ECD(MeOH)λ max (Δε):272(+4.4),235(-3.8),226(-4.0)nm, 1 H-NMR and 13 C-NMR data are shown in Table 1.

[0042] Table 1 Compound 1 1 H(500MHz) and 13 C (125MHz) NMR data (CDCl3, δinppm, JinHz)

[0043]

[0044]

[0045] High resolution mass spectrometry HR-ESI-MS at m / z 1101.3709 [M+Na] + (C 58 H 62 O 20 Na, calculated value 1101.3727), indicating that the molecular formula of compound 1 is C 58 H 62 O20 , the unsaturation is 28. Combining the above data and Figure 1-6 The spectral data finally determined that compound 1 is composed of two 5,6,7,8-tetrahydro-2-(2-phenylethyl) chromone units and a lignan unit connected by two ether bonds.

[0046] Further, according to the key 2D NMR related signals of compound 1 ( Figure 7 ) and CD spectra and chromophore exciton chirality ( Figure 8 ), and finally the structure of compound 1 was determined as Fig. 9 The compound was retrieved from SciFinder and was named aquicrassnol. Its systematic name was (5S,5'S,6R,6'R,7S,7'S,8R,8'R)-8,8'-((((1R,3aS,4R,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2,6-dimethoxy-4,1-phenylene))bis(oxo))bis(5,6,7-trihydroxy-2-(4-methoxyphenethyl)-5,6,7,8-tetrahydro-4H-chromen-4-one).

[0047] Example 2 Anti-inflammatory Activity Test

[0048] 1 Cytotoxic activity

[0049] The MTT method was used to test the cytotoxic activity of compound 1 on mouse mononuclear macrophage RAW264.7 cells. RAW264.7 cells were routinely cultured in a 37°C, 5% CO2 incubator using DMEM culture medium containing 10% FBS. The cells were cultured at 1×10 5 100 μL of MTT solution was added to each well of cells. After 4 hours of reaction at 37°C, the supernatant was aspirated, 100 μL of DMSO was added to each well to fully dissolve, and the absorbance (A) value of each well was measured at 490 nm on an ELISA reader. Each group of experiments was repeated 3 times. The cell growth inhibition rate was calculated according to the formula.

[0050] Inhibition rate (%) = (1-A / A0) × 100%

[0051] A0 and A are the absorbance of the blank group and the experimental group, respectively.

[0052] The experimental results showed that the cell survival rate (1-inhibition rate) of the above compounds was 96% at a concentration of 100 μmol / L, and they had no cytotoxic activity.

[0053] 2 Inhibit the activity of NO production induced by lipopolysaccharide (LPS) in mouse mononuclear macrophage RAW264.7 cells

[0054] The anti-inflammatory activity of compound 1 was tested in the LPS-induced mouse mononuclear macrophage RAW264.7 model. RAW264.7 cells were routinely cultured in a 37°C, 5% CO2 incubator using DMEM containing 10% FBS. 5 / mL were inoculated in 96-well plates and cultured for 24 hours. A control group (without LPS), an LPS-induced group, a positive drug indomethacin group, and different doses of the compound (100, 50, 25, 12.5, 6.25 μmol / L) were set up. After being placed in a 37°C, 5% CO2 cell culture incubator for 24 hours, 100 μL was taken into a new 96-well plate, and then 100 μL (40 mg / mL) of Griess reagent was added to each well. After mixing, the absorbance (A) of each well was measured at a wavelength of 540 nm on an ELISA reader. Each group of experiments was repeated 3 times. The NO inhibition rate was calculated according to the formula. Finally, the data were processed using GraphPadPrism software to obtain the median inhibition concentration (IC) of compound 1 on LPS-induced nitric oxide (NO) production by RAW264.7. 50 ).

[0055] Inhibition rate = (A2-A1) / (A2-A0)

[0056] A0, A1, and A2 are the A values ​​of the control group, drug group, and LPS-induced group, respectively.

[0057] The experimental results showed that compound 1 had the activity of inhibiting LPS-induced NO production in mouse mononuclear macrophage RAW264.7 cells, IC 50 The value is (47.53±2.14)μmol / L. The IC of positive control indomethacin 50 The value is (25.28±1.14)μmol / L.

[0058] The invention discloses a new hybrid aquicrassnol formed by 2-(2-phenylethyl) chromone and lignans, which is firstly found in agarwood produced by A.crassna. The compound has certain inhibitory activity on lipopolysaccharide-induced nitric oxide production in RAW264.7 cell line. 50 The value was (47.53±2.14)μmol / L, which had anti-inflammatory activity.

[0059] The heteropolymers previously isolated from agarwood are all formed by combining one 2-(2-phenylethyl) chromone unit with one sesquiterpene, flavonoid or benzyl acetone unit. The compound 1 described in the present invention is a heteropolymer formed by two 2-(2-phenylethyl) chromone units and one lignan unit connected by COC, and is isolated from agarwood for the first time. The lignan unit is (+)-syringinol, which has never been isolated from agarwood.

[0060] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A 2-(2-phenylethyl) chromone and lignan hybrid, characterized in that: It is named as thick leaf linalool, and its structure is shown in Formula I:

2. The method for preparing a hybrid of 2-(2-phenylethyl) chromone and lignans according to claim 1, characterized in that: The following steps are involved: (1) extracting the dried and crushed agarwood wood by heating and refluxing with ethanol water with a volume concentration of 95%, recovering the ethanol under reduced pressure until there is no alcohol smell, obtaining an ethanol extract, dispersing the ethanol extract with water into a suspension, extracting with acetic acid, and concentrating to obtain an acetic acid extract; (2) subjecting the acetic acid ester extract to vacuum column chromatography and eluting with chloroform-methanol to obtain 11 fractions Fr.1-11; (3) The eighth fraction Fr.8 was subjected to MCI column chromatography and gradient eluted with methanol / water to obtain nine fractions Fr.8-1 to 8-9; the eighth fraction Fr.8-8 was subjected to reverse phase silica gel column chromatography and gradient eluted with methanol-water to obtain five fractions Fr.8-8-1 to 8-8-5; (4) The second fraction Fr.8-8-2 was separated by gel column chromatography and eluted with chloroform-methanol solution to obtain three fractions Fr.8-8-2-1 to 8-8-2-3. The first fraction Fr.8-8-2-1 was purified and separated by semi-preparative high performance liquid chromatography to obtain a compound whose structure is shown in Formula I.

3. The preparation method according to claim 2, characterized in that: In the step (1), the agarwood is agarwood produced by the thick-leaved agarwood plant.

4. The preparation method according to claim 2, characterized in that: In the step (1), reflux extraction is performed 3 times and extraction is performed 3 times.

5. The preparation method according to claim 2, characterized in that: In the step (2), the volume ratio of chloroform to methanol is 1:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9, and 0:1, respectively; in the step (3), the volume ratio of methanol / water used for eluting the fraction Fr.8 is 1:1, 3:2, 7:3, 4:1, 9:1, and 1:0, respectively; the volume ratio of methanol to water used for eluting the fraction Fr.8-8 is 3:7, 2:3, 1:1, 3:2, 7:3, 4:1, 9:1, and 1:0, respectively.

6. The preparation method according to claim 2, characterized in that: In the step (4), the fraction Fr.8-8-2 is separated by Sephadex LH-20 gel column chromatography, and the volume ratio of chloroform to methanol used for elution is 1:

1.

7. The preparation method according to claim 2, characterized in that: In the step (4), the HPLC purification conditions are: C 18 The column was used, the mobile phase was acetonitrile-water in a volume ratio of 2:3, and the flow rate was 4 mL / min; the retention time of the compound represented by formula I was 15.12 min.

8. Use of the 2-(2-phenylethyl) chromone and lignan hybrid as claimed in claim 1 in the preparation of anti-inflammatory preparations.

9. The use according to claim 8, characterized in that The 2-(2-phenylethyl) chromone and lignan hybrid can inhibit the production of nitric oxide by mouse mononuclear macrophage RAW264.7 induced by lipopolysaccharide.

10. An anti-inflammatory preparation, characterized in that It contains the 2-(2-phenylethyl) chromone and lignan hybrid as claimed in claim 1.

Citation Information

Patent Citations

  • Determination method of total 2-(2-phenethyl) chromone compound content

    CN102818782A

  • Chromone compounds separated from Chinese eaglewood and method and application of chromone compounds

    CN105801546A

  • Phenethyl chromone dimer, preparation method thereof, pharmaceutical composition and use

    CN108727322A

  • Agilawood tetrahydro2-(2-phenethyl) chromone compounds, separation method and applications thereof

    CN110818669A

Cited By

  • Sesquiterpene-chromone polymer with neuroprotective effect as well as preparation method and application of sesquiterpene-chromone polymer

    CN122541408A

  • A sesquiterpenoid-chromone polymer with neuroprotective effect and preparation method and application thereof

    CN122541408B